The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global IVIg Liquid Market Research Report 2025
Synopsis
Intravenous immunoglobulin (IVIG) contains the pooled immunoglobulin G (IgG) immunoglobulins from the plasma of approximately a thousand or more blood donors. Most liquid IVIG preparations currently on the market are adjusted to 5% or 10% total protein.
The global IVIg Liquid market was valued at US$ 13220 million in 2023 and is anticipated to reach US$ 21530 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
This report aims to provide a comprehensive presentation of the global market for IVIg Liquid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVIg Liquid.
Report Scope
The IVIg Liquid market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVIg Liquid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVIg Liquid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
50ml
25ml
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of IVIg Liquid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of IVIg Liquid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intravenous immunoglobulin (IVIG) contains the pooled immunoglobulin G (IgG) immunoglobulins from the plasma of approximately a thousand or more blood donors. Most liquid IVIG preparations currently on the market are adjusted to 5% or 10% total protein.
The global IVIg Liquid market was valued at US$ 13220 million in 2023 and is anticipated to reach US$ 21530 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
This report aims to provide a comprehensive presentation of the global market for IVIg Liquid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVIg Liquid.
Report Scope
The IVIg Liquid market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVIg Liquid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVIg Liquid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
50ml
25ml
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of IVIg Liquid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of IVIg Liquid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 IVIg Liquid Market Overview
1.1 Product Overview and Scope of IVIg Liquid
1.2 IVIg Liquid Segment by Type
1.2.1 Global IVIg Liquid Market Value Comparison by Type (2024-2030)
1.2.2 50ml
1.2.3 25ml
1.3 IVIg Liquid Segment by Application
1.3.1 Global IVIg Liquid Market Value by Application: (2024-2030)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global IVIg Liquid Market Size Estimates and Forecasts
1.4.1 Global IVIg Liquid Revenue 2019-2030
1.4.2 Global IVIg Liquid Sales 2019-2030
1.4.3 Global IVIg Liquid Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 IVIg Liquid Market Competition by Manufacturers
2.1 Global IVIg Liquid Sales Market Share by Manufacturers (2019-2024)
2.2 Global IVIg Liquid Revenue Market Share by Manufacturers (2019-2024)
2.3 Global IVIg Liquid Average Price by Manufacturers (2019-2024)
2.4 Global IVIg Liquid Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IVIg Liquid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IVIg Liquid, Product Type & Application
2.7 IVIg Liquid Market Competitive Situation and Trends
2.7.1 IVIg Liquid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest IVIg Liquid Players Market Share by Revenue
2.7.3 Global IVIg Liquid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 IVIg Liquid Retrospective Market Scenario by Region
3.1 Global IVIg Liquid Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global IVIg Liquid Global IVIg Liquid Sales by Region: 2019-2030
3.2.1 Global IVIg Liquid Sales by Region: 2019-2024
3.2.2 Global IVIg Liquid Sales by Region: 2025-2030
3.3 Global IVIg Liquid Global IVIg Liquid Revenue by Region: 2019-2030
3.3.1 Global IVIg Liquid Revenue by Region: 2019-2024
3.3.2 Global IVIg Liquid Revenue by Region: 2025-2030
3.4 North America IVIg Liquid Market Facts & Figures by Country
3.4.1 North America IVIg Liquid Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America IVIg Liquid Sales by Country (2019-2030)
3.4.3 North America IVIg Liquid Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe IVIg Liquid Market Facts & Figures by Country
3.5.1 Europe IVIg Liquid Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe IVIg Liquid Sales by Country (2019-2030)
3.5.3 Europe IVIg Liquid Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IVIg Liquid Market Facts & Figures by Country
3.6.1 Asia Pacific IVIg Liquid Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific IVIg Liquid Sales by Country (2019-2030)
3.6.3 Asia Pacific IVIg Liquid Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America IVIg Liquid Market Facts & Figures by Country
3.7.1 Latin America IVIg Liquid Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America IVIg Liquid Sales by Country (2019-2030)
3.7.3 Latin America IVIg Liquid Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa IVIg Liquid Market Facts & Figures by Country
3.8.1 Middle East and Africa IVIg Liquid Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa IVIg Liquid Sales by Country (2019-2030)
3.8.3 Middle East and Africa IVIg Liquid Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IVIg Liquid Sales by Type (2019-2030)
4.1.1 Global IVIg Liquid Sales by Type (2019-2024)
4.1.2 Global IVIg Liquid Sales by Type (2025-2030)
4.1.3 Global IVIg Liquid Sales Market Share by Type (2019-2030)
4.2 Global IVIg Liquid Revenue by Type (2019-2030)
4.2.1 Global IVIg Liquid Revenue by Type (2019-2024)
4.2.2 Global IVIg Liquid Revenue by Type (2025-2030)
4.2.3 Global IVIg Liquid Revenue Market Share by Type (2019-2030)
4.3 Global IVIg Liquid Price by Type (2019-2030)
5 Segment by Application
5.1 Global IVIg Liquid Sales by Application (2019-2030)
5.1.1 Global IVIg Liquid Sales by Application (2019-2024)
5.1.2 Global IVIg Liquid Sales by Application (2025-2030)
5.1.3 Global IVIg Liquid Sales Market Share by Application (2019-2030)
5.2 Global IVIg Liquid Revenue by Application (2019-2030)
5.2.1 Global IVIg Liquid Revenue by Application (2019-2024)
5.2.2 Global IVIg Liquid Revenue by Application (2025-2030)
5.2.3 Global IVIg Liquid Revenue Market Share by Application (2019-2030)
5.3 Global IVIg Liquid Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda IVIg Liquid Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols IVIg Liquid Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL IVIg Liquid Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma IVIg Liquid Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Corporation Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biotest IVIg Liquid Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kedrion IVIg Liquid Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hualan Bio IVIg Liquid Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CNBG IVIg Liquid Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai RAAS IVIg Liquid Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO IVIg Liquid Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Corporation Information
6.11.2 LFB Group IVIg Liquid Description and Business Overview
6.11.3 LFB Group IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LFB Group IVIg Liquid Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Corporation Information
6.12.2 BPL IVIg Liquid Description and Business Overview
6.12.3 BPL IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BPL IVIg Liquid Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Corporation Information
6.13.2 Sichuan Yuanda Shuyang IVIg Liquid Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang IVIg Liquid Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sichuan Yuanda Shuyang IVIg Liquid Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IVIg Liquid Industry Chain Analysis
7.2 IVIg Liquid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IVIg Liquid Production Mode & Process
7.4 IVIg Liquid Sales and Marketing
7.4.1 IVIg Liquid Sales Channels
7.4.2 IVIg Liquid Distributors
7.5 IVIg Liquid Customers
8 IVIg Liquid Market Dynamics
8.1 IVIg Liquid Industry Trends
8.2 IVIg Liquid Market Drivers
8.3 IVIg Liquid Market Challenges
8.4 IVIg Liquid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
